RecallRadar

FDA Drug recall D-260-2013

Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60…

On 2013-04-24 the FDA classified a Class II recall of Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60… by Pfizer, citing chemical contamination: emission of strong odor after package was opened.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-260-2013
ClassificationClass II
Statuscompleted
Initiated2013-03-28
Published2013-04-24
Last updated2026-09-13 11:51 UTC
CompanyPfizer
DistributionUS

Product

Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles ( NDC 60793-859-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Reason

Chemical contamination: emission of strong odor after package was opened.

Identifiers

ndc60793-850-10
ndc60793-850-01
ndc60793-851-10
ndc60793-851-01
ndc60793-852-10
ndc60793-852-01
ndc60793-853-10
ndc60793-853-01
ndc60793-854-10
ndc60793-854-01
ndc60793-855-10
ndc60793-855-01
ndc60793-856-10
ndc60793-856-01
ndc60793-857-10
ndc60793-857-01
ndc60793-858-10
ndc60793-858-01
ndc60793-859-10
ndc60793-859-01
ndc60793-860-10
ndc60793-860-01
code_infoLot # a) 67507B, Exp. 02/14; b) 67508B, Exp. 02/14

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-260-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.